Evidence map›Paper›PMID 33081396›Full record

ArticleInternational journal of molecular sciences2020

Calcium Ionophore-Induced Extracellular Vesicles Mediate Cytoprotection against Simulated Ischemia/Reperfusion Injury in Cardiomyocyte-Derived Cell Lines by Inducing Heme Oxygenase 1.

Peter Pečan, Szabolcs Hambalkó, Van Thai Ha, Csilla T Nagy, Csilla Pelyhe, Duško Lainšček, Bence Kenyeres, Gábor B Brenner, Anikó Görbe, Ágnes Kittel and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Exosome is a Fancy Mobile Sower of Ferroptosis.Journal of cardiovascular translational research · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Extracellular Vesicles in Neurodegenerative Diseases: An Update.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Peter PečanNational Institute of Chemistry, SI-1000 Ljubljana, Slovenia.
Szabolcs HambalkóDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0003-3638-0394
Van Thai HaNational Institute of Chemistry, SI-1000 Ljubljana, Slovenia.
Csilla T NagyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Csilla PelyheDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0001-6267-4527
Duško LainščekNational Institute of Chemistry, SI-1000 Ljubljana, Slovenia.
Bence KenyeresDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Gábor B BrennerDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Anikó GörbeDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Ágnes KittelInstitute of Experimental Medicine, ELRN, 1083 Budapest, Hungary.ORCID 0000-0002-6888-7731
Monika BartekováCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.ORCID 0000-0002-5210-5184
Péter FerdinandyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Mateja Manček-KeberNational Institute of Chemistry, SI-1000 Ljubljana, Slovenia.ORCID 0000-0003-4976-8857
Zoltán GiriczDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.
Semmelweis University · HUEN-FIST Centre of Excellence (Slovenia) · SIUniversity of Ljubljana · SIHUN-REN Institute of Experimental Medicine · HUSlovak Academy of Sciences · SK

Funding

Emberi Eroforrások Minisztériuma Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Therapeutic development thematic programme of the Semmelweis UniversityEmberi Eroforrások Minisztériuma ÚNKP-19-4 New National Excellence ProgramEuropean Cooperation in Science and Technology BM1203 EU-ROSH2020 Marie Skłodowska-Curie Actions MSC-ETN-642157 project TOLLerantJavna Agencija za Raziskovalno Dejavnost RS J3-9257 to M.M.K.; bilateral project BI-HU/17-18-010 to M.M.K and Z.G.Magyar Tudományos Akadémia Számítástechnikai és Automatizálási Kutatóintézet ZG: János Bolyai Research ScholarshipsMinisterstvo školstva, vedy, výskumu a športu Slovenskej republiky VEGA no. 2/0061/16 and 2/0104/20Nemzeti Kutatási, Fejlesztési és Innovaciós Alap VEKOP-2.3.2-16-2016-00002, TÉT_16-1-2016-0057, NVKP_16-1-2016-0017
6 · The paper itself

Abstract

Cardioprotection against ischemia/reperfusion injury is still an unmet clinical need. The transient activation of Toll-like receptors (TLRs) has been implicated in cardioprotection, which may be achieved by treatment with blood-derived extracellular vesicles (EVs). However, since the isolation of EVs from blood takes considerable effort, the aim of our study was to establish a cellular model from which cardioprotective EVs can be isolated in a well-reproducible manner. EV release was induced in HEK293 cells with calcium ionophore A23187. EVs were characterized and cytoprotection was assessed in H9c2 and AC16 cell lines. Cardioprotection afforded by EVs and its mechanism were investigated after 16 h simulated ischemia and 2 h reperfusion. The induction of HEK293 cells by calcium ionophore resulted in the release of heterogenous populations of EVs. In H9c2 and AC16 cells, stressEVs induced the downstream signaling of TLR4 and heme oxygenase 1 (HO-1) expression in H9c2 cells. StressEVs decreased necrosis due to simulated ischemia/reperfusion injury in H9c2 and AC16 cells, which was independent of TLR4 induction, but not that of HO-1. Calcium ionophore-induced EVs exert cytoprotection by inducing HO-1 in a TLR4-independent manner.

Indexed as

AnimalsCalcimycinCalcium IonophoresCell DeathExosomesHEK293 CellsHeme Oxygenase-1HumansMiceMyocardial Reperfusion InjuryMyocytes, CardiacRatsToll-Like Receptor 4CalcimycinCalcium IonophoresHeme Oxygenase-1Toll-Like Receptor 4cardioprotectionextracellular vesiclesHO-1ischemia/reperfusion injuryTLR4

Identifiers

PMID33081396
PMCPMC7589052
OpenAlexW3093098589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.